Hydrocortisone Sodium Succinate Injection Shortage
Last Updated: May 20, 2025
Status: Current
Products Affected - Description
-
- Solu-Cortef injection, Pfizer, 125 mg/mL, 2 mL vial, 1 count, NDC 00009-0013-05
- Solu-Cortef injection, Pfizer, 125 mg/mL, 2 mL vial, 25 count, NDC 00009-0013-06
- Solu-Cortef injection, Pfizer, 125 mg/mL, 4 mL vial, 1 count, NDC 00009-0016-12
- Solu-Cortef injection, Pfizer, 125 mg/mL, 8 mL vial, 1 count, NDC 00009-0005-01
- Solu-Cortef injection, Pfizer, 50 mg/mL, 2 mL vial, 1 count, NDC 00009-0011-03
- Solu-Cortef injection, Pfizer, 50 mg/mL, 2 mL vial, 25 count, NDC 00009-0011-04
- Solu-Cortef lyophilized powder for injection, Pfizer, 100 mg vial, 1 count, NDC 00009-0825-01
Reason for the Shortage
-
- Pfizer has Solu-Cortef on shortage due to manufacturing delays.
Available Products
-
- There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Pfizer has Solu-Cortef 100 mg vials on back order and the company estimates a release date of July 2025. All other presentations are available in limited supply.
Updated
Updated May 20, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 1, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.